Impact of Ibis on Patients With Advanced COPD

Impact of Ibis, a Digital Health Solution for Patient Activation and Early Intervention, on Acute Care Utilization by Patients With Advanced COPD

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03131622

Enrollment

240

Registered

2017-04-27

Start date

2016-12-31

Completion date

2018-01-31

Last updated

2017-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients with COPD.

Interventions

BEHAVIORALDigital Therapeutics

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Gold Stage II with a CAT Score above 19 * Gold Stage III/IV with a CAT Score above 14

Exclusion criteria

* Cognitive or physical impediments that inhibits patients from interacting with our digital therapeutics platform.

Design outcomes

Primary

Measure	Time frame
Reduction in Acute Care Utilization	6 months and then again at 1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026